Immunomodulation with methotrexate: Underused and undervalued?

Digestive Diseases

Volumn 27, Issue 3, 2009, Pages 312-314

  Ruemmele, Frank M ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Azathioprine; Clinical remission; Crohn's disease; Inflammatory bowel disease; Methotrexate

Indexed keywords

AZATHIOPRINE; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; PLACEBO; TUMOR NECROSIS FACTOR INHIBITOR;

B CELL LYMPHOMA; CLINICAL TRIAL; CONFERENCE PAPER; CROHN DISEASE; DISEASE CONTROL; DISEASE COURSE; DRUG EFFICACY; DRUG TOLERANCE; DRUG WITHDRAWAL; ENTERITIS; FOLLOW UP; HERPES ZOSTER; HUMAN; IMMUNOMODULATION; MONOTHERAPY; NAUSEA; PRIORITY JOURNAL; REMISSION; SEPSIS; SIDE EFFECT;

AZATHIOPRINE; CLINICAL TRIALS AS TOPIC; CROHN DISEASE; HUMANS; IMMUNE TOLERANCE; IMMUNOLOGIC FACTORS; IMMUNOMODULATION; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE;

EID: 70349896202     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000228566     Document Type: Conference Paper

References (15)

1. Targan SR: Current limitations of IBD treatment: where do we go from here? Ann NY Acad Sci 2006; 1072: 1-8.
2. Baumgart DC, Sandborn WJ: Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007; 369: 1641-1657. (Pubitemid 46722637)
3. Sturm A, de Souza HS, Fiocchi C: Mucosal T cell proliferation and apoptosis in inflammatory bowel disease. Curr Drug Targets 2008; 9: 381-387. (Pubitemid 352025212)
4. Atreya R, Mudter J, Finotto S, Müllberg J, Jostock T, Wirtz S, Schütz M, Bartsch B, Holtmann M, Becker C, Strand D, Czaja J, Schlaak JF, Lehr HA, Autschbach F, Schürmann G, Nishimoto N, Yoshizaki K, Ito H, Kishimoto T, Galle PR, Rose-John S, Neurath MF: Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Nat Med 2000; 6: 583-588. (Pubitemid 30305911)
5. Doering J, Begue B, Lentze MJ, Rieux-Laucat F, Goulet O, Schmitz J, Cerf-Bensussan N, Ruemmele FM: Induction of T lymphocyte apoptosis by sulphasalazine in patients with Crohn's disease. Gut 2004; 53: 1632-1638. (Pubitemid 39434107)
6. Sandborn W, Sutherland L, Pearson D, May G, Modigliani R, Prantera C: Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease. Cochrane Database Syst Rev 2000;2:CD000545.
7. Prefontaine E, Sutherland LR, Macdonald JK, Cepoiu M: Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2009; 1:CD000067.
8. Markowitz J, Grancher K, Kohn N, Lesser M, Daum F: A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology 2000; 119: 895-902. (Pubitemid 30777909)
9. Uhlen S, Belbouab R, Narebski K, Goulet O, Schmitz J, Cézard JP, Turck D, Ruemmele FM: Efficacy of methotrexate in pediatric Crohn's disease: a French multicenter study. Inflamm Bowel Dis 2006; 12: 1053-1057. (Pubitemid 44665475)
10. Turner D, Grossman AB, Rosh J, Kugathasan S, Gilman AR, Baldassano R, Griffiths AM: Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease. Am J Gastroenterol 2007; 102: 2804-2812. (Pubitemid 350179322)
11. Feagan BG, Rochon J, Fedorak RN, Irvine EJ, Wild G, Sutherland L, Steinhart AH, Greenberg GR, Gillies R, Hopkins M, et al: Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators. N Engl J Med 1995; 332: 292-297.
12. Feagan BG, Fedorak RN, Irvine EJ, Wild G, Sutherland L, Steinhart AH, Greenberg GR, Koval J, Wong CJ, Hopkins M, Hanauer SB, McDonald JW: A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. N Engl J Med 2000; 342: 1627-1632.
13. Cucchiara S, Escher JC, Hildebrand H, Amil-Dias J, Stronati L, Ruemmele FM: Pediatric inflammatory bowel diseases and the risk of lymphoma: should we revise our treatment strategies? J Pediatr Gastroenterol Nutr 2009; 48: 257-267.
14. Hyams J, Crandall W, Kugathasan S, Griffiths A, Olson A, Johanns J, Liu G, Travers S, Heuschkel R, Markowitz J, Cohen S, Winter H, Veereman-Wauters G, Ferry G, Baldassano R; REACH Study Group: Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. Gastroenterology 2007; 132: 863-873. (Pubitemid 46454266)
15. Ruemmele FM, Lachaux A, Cézard JP, Morali A, Maurage C, Giniès JL, Viola S, Goulet O, Lamireau T, Scaillon M, Breton A, Sarles J; Groupe Francophone d'Hépatologie, Gastroentérologie et Nutrition Pédiatrique: Efficacy of infliximab in pediatric Crohn's disease: a randomized multicenter open-label trial comparing scheduled to on demand maintenance therapy. Inflamm Bowel Dis 2009; 15: 388-394.